Breaking News Instant updates and real-time market news.

IFRX

InflaRx

$33.27

0.06 (0.18%)

07:25
09/07/18
09/07
07:25
09/07/18
07:25

InflaRx to host research and development day

Research and Development Day on Hidradenitis Suppurativa and its Breakthrough Anti-C5a Monoclonal Antibody IFX-1 will be held in New York on September 7 at 7:45 am. Webcast Link

  • 07

    Sep

IFRX InflaRx
$33.27

0.06 (0.18%)

06/28/18
RAJA
06/28/18
INITIATION
Target $44
RAJA
Outperform
InflaRx initiated with an Outperform at Raymond James
Raymond James analyst Steven Seedhouse initiated InflaRx with an Outperform and $44 price target.
06/28/18
RHCO
06/28/18
INITIATION
Target $55
RHCO
Buy
InflaRx initiated with a Buy at SunTrust
As reported earlier, SunTrust analyst Yatin Suneja initiated InflaRx with a Buy rating and a price target of $55. The analyst says the company's only clinical candidate IFX-1 has produced "promising Phase 2a data in hidradenitis suppurativa skin disease", adding that he is optimistic about the program's success in the Phase 2b trial which is expected to yield initial data in the first half of FY19. Suneja believes that IFX-1 could achieve peak global sales of about $2B.
07/13/18
BMOC
07/13/18
INITIATION
Target $45
BMOC
Outperform
InflaRx initiated with an Outperform at BMO Capital
BMO Capital analyst Matthew Luchini initiated InflaRx with an Outperform and $45 price target.
07/13/18
BMOC
07/13/18
INITIATION
Target $45
BMOC
Outperform
InflaRx initiated with an Outperform at BMO Capital
As reported earlier, BMO Capital analyst Matthew Luchini initiated InflaRX (IFRX) with an Outperform rating and a price target of $45. The analyst notes that the company's IFX-1 "could be a best-in-class treatment for hidradenitis suppurativa" skin diseas, with initial data suggesting a "better clinical profile" than Humira. Luchini adds that the strength of IFX-1's Phase IIa data de-risks the ongoing Phase IIb trial, also stating that "IFX-1's targeting of C5a could be an advantage over emerging competitor avacopan" made by ChemoCentryx (CCXI).

TODAY'S FREE FLY STORIES

HCSG

Healthcare Services

$41.68

0.035 (0.08%)

08:43
12/10/18
12/10
08:43
12/10/18
08:43
Recommendations
Healthcare Services analyst commentary  »

Healthcare Services…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AU

AngloGold

$11.30

0.44 (4.05%)

08:43
12/10/18
12/10
08:43
12/10/18
08:43
Initiation
AngloGold initiated  »

AngloGold initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INPX

Inpixon

$3.58

0.04 (1.13%)

08:42
12/10/18
12/10
08:42
12/10/18
08:42
Hot Stocks
Inpixon receives notice of allowance for IPA platform patent from USPTO »

Inpixon announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GCAP

Gain Capital

$7.23

0.03 (0.42%)

08:42
12/10/18
12/10
08:42
12/10/18
08:42
Hot Stocks
GAIN Capital reports November operating metrics »

In the retail segment in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMRS

Amyris

$4.33

0.16 (3.84%)

08:40
12/10/18
12/10
08:40
12/10/18
08:40
Hot Stocks
Amyris expands production agreement with ADL Bionatur »

Amyris announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IFRX

InflaRx

$29.94

0.44 (1.49%)

08:39
12/10/18
12/10
08:39
12/10/18
08:39
Initiation
InflaRx initiated  »

InflaRx initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

CLPS

CLPS

$6.30

(0.00%)

08:39
12/10/18
12/10
08:39
12/10/18
08:39
Hot Stocks
CLPS signs MOU with Ngee Ann Polytechnic, Infogain Solutions »

CLPS announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RY

Royal Bank of Canada

$71.07

-0.55 (-0.77%)

08:39
12/10/18
12/10
08:39
12/10/18
08:39
Upgrade
Royal Bank of Canada rating change  »

Royal Bank of Canada…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Jan

IDCC

InterDigital

$72.10

-1.93 (-2.61%)

08:38
12/10/18
12/10
08:38
12/10/18
08:38
Hot Stocks
InterDigital announces $100M increase to stock repurchase program »

InterDigital's board…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

GFI

Gold Fields

$3.18

0.065 (2.09%)

08:37
12/10/18
12/10
08:37
12/10/18
08:37
Initiation
Gold Fields initiated  »

Gold Fields initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SDI

Standard Diversified

$13.50

(0.00%)

08:37
12/10/18
12/10
08:37
12/10/18
08:37
Hot Stocks
Standard Diversified to acquire Tri-State Consumer Insurance for approx. $54.1M »

Standard Diversified…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NUVA

NuVasive

$56.17

-1.68 (-2.90%)

08:37
12/10/18
12/10
08:37
12/10/18
08:37
Hot Stocks
NuVasive gets FDA clearance for expanded use of Monolith Corpectomy System »

NuVasive announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:36
12/10/18
12/10
08:36
12/10/18
08:36
Conference/Events
Raymond James to hold al symposium »

Multi-Family Lending…

BCSF

Bain Capital Specialty Finance

$18.04

-0.13 (-0.72%)

08:36
12/10/18
12/10
08:36
12/10/18
08:36
Initiation
Bain Capital Specialty Finance initiated  »

Bain Capital Specialty…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IDCC

InterDigital

$72.10

-1.93 (-2.61%)

08:36
12/10/18
12/10
08:36
12/10/18
08:36
Earnings
Breaking Earnings news story on InterDigital »

InterDigital sees Q4…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

CULP

Culp, Inc.

$20.43

-0.3 (-1.45%)

08:35
12/10/18
12/10
08:35
12/10/18
08:35
Hot Stocks
Culp, Inc. announcing passing of chairman, founder Robert Culp, III »

Culp, Inc. announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TAP

Molson Coors

$63.39

-1.04 (-1.61%)

08:35
12/10/18
12/10
08:35
12/10/18
08:35
Conference/Events
Molson Coors to hold a tour »

Molson Coors HQ &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

MDRX

Allscripts

$9.49

-0.01 (-0.11%)

08:35
12/10/18
12/10
08:35
12/10/18
08:35
Hot Stocks
Allscripts to sell interests in Netsmart for after-tax proceeds of $3 per share »

Allscripts announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SHLX

Shell Midstream

08:34
12/10/18
12/10
08:34
12/10/18
08:34
Downgrade
Shell Midstream rating change  »

Shell Midstream…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BPMP

BP Midstream

$16.74

-0.16 (-0.95%)

08:34
12/10/18
12/10
08:34
12/10/18
08:34
Downgrade
BP Midstream rating change  »

BP Midstream downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ONCS

OncoSec

$0.81

-0.0557 (-6.40%)

08:34
12/10/18
12/10
08:34
12/10/18
08:34
Hot Stocks
OncoSec receives $7M investment from Alpha Holdings at $1.50 per share »

OncoSec Medical announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CERS

Cerus

$5.35

-0.22 (-3.95%)

08:32
12/10/18
12/10
08:32
12/10/18
08:32
Hot Stocks
Cerus announces American Red Cross receives BLA approval for INTERCEPT platelets »

Cerus Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDRX

Allscripts

$9.49

-0.01 (-0.11%)

08:32
12/10/18
12/10
08:32
12/10/18
08:32
Hot Stocks
GI Partners, TA Associates to acquire Allscripts' stake in Netsmart Technologies »

GI Partners together with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDRX

Allscripts

$9.49

-0.01 (-0.11%)

08:31
12/10/18
12/10
08:31
12/10/18
08:31
Hot Stocks
Breaking Hot Stocks news story on Allscripts »

GI Partners, TA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FCE/A

Forest City Enterprises Inc

$0.00

(0.00%)

, OVAS

OvaScience

$0.70

-0.0335 (-4.57%)

08:30
12/10/18
12/10
08:30
12/10/18
08:30
Options
One new option listing and three option delistings on December 10th »

New option listings for…

FCE/A

Forest City Enterprises Inc

$0.00

(0.00%)

OVAS

OvaScience

$0.70

-0.0335 (-4.57%)

SONC

Sonic

$43.48

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.